title: [Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011].
abstract: BACKGROUND
  In Catalonia, as in most Spanish regions, the conjugate pneumococcal vaccine is not publicly funded, except for immunocompromised or high-risk children. This study assessed current vaccine coverage in the region of Tarragona, analyzing trends in vaccine uptakes throughout the 2002-2011 period by analyzing uptakes by year of birth.
  
  
  METHODS
  Cross-sectional multicenter study that included all children <10 years attended between 01/12/2011 and 02/12/2011 in pediatric ambulatory visits in 9 Primary Care Centers in the region of Tarragona (N=521 children). Pneumococcal vaccine status was determined after clinical record review. Vaccine coverages were compared by chi-squared test.
  
  
  RESULTS
  Among the total 521 children, 45.1% (95% confidence interval [CI]: 40.8-49.5) had received CPV. Vaccine coverages were 18.5% (95% CI: 9.3-31.4) for children born between 2002-2003, 38.6% (95% CI: 27.2-51.0) in 2004-2005, 62.5% (95% CI: 51.0-73.0) in 2006-2007, 50.8% (95% CI: 41.7-59.8) in 2008-2009 and 44.6% (95% CI: 36.8-51.3) in 2010-2011 (p<0.001).
  
  
  CONCLUSIONS
  Vaccine coverage can be considered as intermediate/low. In our population, after a rapid initial increase, vaccination uptakes have decreased in the last 4 years, coinciding with the current economic crisis. In our population, after a rapid initial increase, vaccination uptakes have decreased in the last 4 years.
authors: Dirección de Atención Primaria del Camp de Tarragona, Institut Català de la Salut, C/ Prat de la Riba, Tarragona.
authors: Angel
authors: A
authors: Vila Córcoles
authors: Olga
authors: O
authors: Ochoa Gondar
authors: Antonia
authors: A
authors: Gutiérrez Pérez
authors: Cinta
authors: C
authors: de Diego Cabanes
authors: Anna
authors: A
authors: Vila Rovira
authors: Beatriz
authors: B
authors: González Lamban
mesh_terms: D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D005382:Financing, Personal; D006801:Humans; D007223:Infant; D008297:Male; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D013030:Spain; D014611:Vaccination / Q000706:statistics & numerical data*; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000276:immunology
chemical_list: D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate